High levels of interleukin-6 in serum and tumor tissue suggest it may potentiate the rare metastasis of cardiac myxoma to the brain.
Answers are grounded in this paper and cite their sources.
IL-6 elevation in myxoma may signal metastatic risk; hypothesis-generating and should not change practice.
Metastasis of a cardiac myxoma to the brain is extremely rare. We present the case of a 70-year-old man who had an atrial myxoma and two metastatic myxomas in the brain. The intracranial lesions were in fact diagnosed before the cardiac myxoma, since the patient developed hemiparesis before his cardiac symptoms occurred. Computerized tomography of the brain showed two high-density lesions, the larger of which was removed surgically. Follow-up computerized tomography revealed a progressive enlargement of the second lesion which was then resected. Histopathological examination showed all lesions to the benign myxomas. Interestingly, high concentrations of interleukin-6 were present in the patient's serum and cardiac myxoma. Interleukin-6 may possibly potentiate metastasis of cardiac myxoma.
No takes yet. Share an insight, caveat, or question.
Wada et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: